Provided by Tiger Trade Technology Pte. Ltd.

Compugen

2.04
-0.0200-0.97%
Post-market: 2.060.0200+0.98%18:38 EDT
Volume:141.85K
Turnover:290.45K
Market Cap:192.89M
PE:5.39
High:2.09
Open:2.04
Low:2.01
Close:2.06
52wk High:2.38
52wk Low:1.13
Shares:94.55M
Float Shares:91.62M
Volume Ratio:0.87
T/O Rate:0.15%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3783
EPS(LYR):0.3783
ROE:44.84%
ROA:14.42%
PB:1.88
PE(LYR):5.39

Loading ...

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 02

Compugen Ltd expected to post earnings of 5 cents a share - Earnings Preview

Reuters
·
Feb 27

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Feb 27

Compugen to Join Oppenheimer 36th Annual Healthcare Life Sciences Conference Fireside Chat

Reuters
·
Feb 19

Compugen Ltd. to Release Fourth Quarter and Full Year Results

Reuters
·
Feb 17

Compugen Announces The Appointment Of Michele Holcomb, Ph.D., To Its Board Of Directors

Reuters
·
Feb 12

Compugen Appoints Michele Holcomb to Board of Directors

Reuters
·
Feb 12

Press Release: Compugen Announces the Appointment of Michele Holcomb, Ph.D., to its Board of Directors

Dow Jones
·
Feb 12

HC Wainwright Initiates Compugen at Buy With $4 Price Target

MT Newswires Live
·
Jan 07

Compugen Shares Rise On Monetization of Cancer Drug Royalties to AstraZeneca

Dow Jones
·
Dec 17, 2025

Compugen Sells Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to $90 Million

Reuters
·
Dec 17, 2025

Compugen’s Earnings Call: Strategic Focus Amid Financial Challenges

TIPRANKS
·
Nov 11, 2025

Clinical-stage cancer immunotherapy firm Compugen's Q3 net loss widens

Reuters
·
Nov 10, 2025

Compugen reports third quarter revenue of $1.9 million and cash position of $86.1 million

Reuters
·
Nov 10, 2025

Compugen Q3 EPS $(0.07) Beats $(0.09) Estimate, Sales $1.891M Beat $1.469M Estimate

Benzinga
·
Nov 10, 2025

Press Release: Compugen Reports Third Quarter 2025 Results

Dow Jones
·
Nov 10, 2025

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Nov 10, 2025

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Nov 07, 2025

Compugen Ltd. to Join Stifel 2025 Healthcare Conference

Reuters
·
Nov 04, 2025

Compugen Announces Interim Analysis Timeline for MAIA-Ovarian Trial of COM701 as Maintenance Therapy in Platinum-Sensitive Ovarian Cancer

Reuters
·
Oct 13, 2025